Conference Coverage (12th World AIDS)
Hypertension May Limit New AIDS Therapy Approach
Published in Vaccine Weekly, September 7th, 1998
Such strategies would block or down-regulate the CCR5 chemokine receptor needed for macrophage-tropic (M-tropic) HIV-1 strains to infect cells. M-tropic strains are responsible for the vast majority of HIV infections.
People homozygous for a naturally occurring mutation that inactivates the CCR5 receptor resist HIV infection and appear healthy. Researchers are thus seeking a drug or immune therapy that would reproduce this condition. But a new study shows that people with the CCR5-delta32/delta32 mutation are at increased risk of hypertension, and that they appear to have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1998-09-07)
More Articles from Vaccine Weekly
- Conference Coverage (12th World AIDS)
HIV (beta)-Chemokine Levels Aid AIDS Vaccines - Conference Coverage (12th World AIDS)
Gallo: Too Soon To Focus Solely on AIDS Vaccine - Conference Coverage (12th World AIDS)
Most Cost-Effective U.S. Technology: AIDS Drugs - Conference Coverage (12th World AIDS)
New HIV Trick: Immunization Against Antiviral Chemokines - Conference Coverage (12th World AIDS)
Uninfected Sex Workers Yield Clues to AIDS Vaccine - Conference Coverage (12th World AIDS)
Vaccination With HIV DNA Induces Anti-HIV Chemokines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
